A recent multicenter trial investigated the impact of potassium nitrate supplementation on exercise capacity and quality of life in patients with heart failure with preserved ejection fraction, revealing interesting insights into blood nitric oxide metabolites.
A recent report in JAMA Ophthalmology reveals that Jardiance, an oral diabetes drug, may help prevent worsening of diabetic eye disease in patients with type 2 diabetes, offering valuable insights for clinical management.
In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.
New guidelines for congenital heart disease screening recommend a single retest and require ≥95% oxygen saturation in both pre- and post-ductal measurements, aiming to simplify detection while maintaining accuracy.
Expanded preoperative evaluations can reduce postoperative delirium by 23% in older adults, but frailty doubles the risk—are your patients screened effectively?
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A recent study shows that even 3.4 minutes of vigorous intermittent lifestyle physical activity per day could significantly reduce cardiovascular risk, particularly in non-exercising women.
Meta-analysis of nearly 1,000 stroke patients found endovascular therapy doubled odds of functional independence and reduced mortality in vertebrobasilar occlusion, despite increased hemorrhage risk—mirroring benefits seen in anterior circulation strokes.
A deep learning algorithm achieved 72% accuracy in identifying ischaemic stroke lesions on brain CT scans. It showed higher accuracy for follow-up scans compared to baseline scans and could be a vital development in AI systems using routine clinical scans.
Study finds women are nearly twice as likely as men to report statin-associated diabetes mellitus, with atorvastatin showing the highest reporting disparity, according to Food and Drug Administration’s Adverse Event Reporting System data.